Hepatocellular Carcinoma

A 5-year longitudinal observational study of patients with hepatocellular carcinoma (TARGET–HCC)

Sponsor: TARGET PharmaSolutions

Enrollment status: OPEN


The goal of this research study is to observe any the clinical course of patients diagnosed with HCC in a "real-life" setting. Researchers are interested in collecting information and blood/tissue samples in order to develop predictors of disease progression.

Inclusion criteria

Exclusion criteria

Study design

Principal investigator

Contact person